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Abstract 
Traditional methods of isolating membrane proteins involve the use of detergents 
that destabilize the membrane environment.  Biophysical studies of membrane proteins 
are challenged by the requirement of a stable membrane platform.  Lipodisq® nano-
particles are novel membrane mimetics that consist of 3:1 styrene-maleic acid copolymer 
encircling phospholipids to form discoidal species on the order of 10 nm in diameter.  
Bacteriorhodopsin was previously incorporated into Lipodisq® nano-particles from its 
native purple membrane without the addition of detergent.  In this study, dynamic light 
scattering was used to investigate the stability of empty Lipodisq® nano-particles over 
time.  These data show that Lipodisq® nano-particles are stable for up to 48 hours at both 
20 and 30°C.  At each temperature, Lipodisq® nano-particles consist of greater than 95% 
of the total volume of the sample.  Therefore, it is reasonable to investigate the properties 
of lipids and membrane proteins in Lipodisq® nano-particles using experimental 
techniques that require up to 48 hours. 
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Chapter I. Introduction 
1.1 Biological Membranes and Membrane Proteins  
Biological membranes of cells and organelles delineate environments for different 
functional purposes.  The major molecular species composing the biological membrane 
include phospholipids, sterols, and proteins.  The phospholipid bilayer is a two 
dimensional array of amphipathic lipids consisting of a charged, polar phosphate head 
group and two nonpolar acyl chains of varying degrees of carbon length and unsaturation.  
Common phospholipid head groups include phosphatidylcholine, 
phosphatidylethanolamine, phosphatidylserine and phosphatidylglycerol.  The acyl 
chains lengths are typically in the range of 16 to 22 carbons (1).  However, longer and 
shorter chain lengths are not uncommon.  
In general, lipids undergo a gel to liquid crystalline phase transition at a 
characteristic melting temperature.  Below the melting temperature, lipid acyl chains are 
rigid and packed closely together in the gel phase. As the temperature is increased, lipids 
pass a pre-transition into a ripple phase where the acyl chains have greater movement. 
Finally, when the temperature reaches the main transition, the acyl chains adopt more 
entropically favorable conformations with the greater degrees of freedom. Points of 
unsaturation in the carbon backbone of acyl chains introduce rigid angles of rotation that 
ultimately increases the disorder of the bilayer(1). 
Biological membranes contain integral membrane proteins and surrounding 
peripheral proteins. Integral membrane proteins traverse the phospholipid bilayer to 
interact with lipid acyl chains, while peripherally associated proteins face one side of the 
phospholipid bilayer to interact with lipid head groups and the aqueous environment. 
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Important interactions within the lipid bilayer occur between the transmembrane regions 
of the integral membrane protein and lipid acyl chains as well as between the extra-
membranous portions of the protein and lipid head groups. Integral membrane proteins 
belong to multiple functional classes such as receptors, transporters, channels, and 
enzymes. 
 
1.2 The purple membrane and bacteriorhodopsin  
Expressed in the plasma membrane of Halobacterium salinarum, 
bacteriorhodopsin (BR) is an integral membrane protein that consists of seven 
transmembrane alpha helices.  BR self-associates into trimers in the purple membrane 
(PM) as part of a hexagonal two-dimensional array (2).  It has a chromophore, all-trans 
retinal that has a maximal absorbance at 568 nm and a molar extinction coefficient (ε) of 
63,000 M-1cm-1 (3).  Upon activation of its photocycle by green light, it generates an 
electrochemical gradient by pumping protons across the membrane.  This gradient is used 
by ATP synthase to synthesize ATP in the cytoplasm (4).  The structure of BR served as 
a model for other alpha helical membrane proteins prior to the determination of the 
crystal structure of rhodopsin, the archetypical G-protein coupled receptor(5).  
 
1.3 Challenges in studying membrane proteins 
It is important to study the physical properties of membrane proteins in a well-
defined, native-like environment so that experimental observations reflect the underlying 
biology.  The amphipathic nature and topological considerations of membrane proteins 
introduce additional challenges that are not considerations for studying soluble proteins 
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(6).  These challenges begin with limitations of obtaining sufficient quantities of protein 
for study.  Different techniques require different amounts of protein. Obtaining 
membrane proteins in high yield is limited by low levels of membrane protein expressed 
in cells and further loss of protein in the purification process (6).  Following this, 
membrane proteins must be reconstituted into well-defined model membrane systems that 
provide a stable environment for study.  Traditionally, membrane proteins have been 
effectively isolated by detergents and studied as a solubilized species in the detergent 
micelle.  Alternatively, they have been incorporated into membrane mimetic platforms 
(6).  Both detergent and membrane mimetics have associated disadvantages, including 
dimensions, limited accessibility of the protein, and decreased protein stability that can 
inhibit effective membrane protein studies. Lipodisq® nano-particles are a model 
membrane system with an ability to overcome these disadvantages (6, 7). 
 
 1.4 Detergents  
Detergents are amphipathic molecules that are commonly used to disrupt the 
membrane and remove membrane proteins directly from their native environment.  
Detergent solubilization progresses along a detergent concentration gradient as follows.  
First, detergent monomers partition into the membrane and begin to destabilize it.  When 
the detergent concentration exceeds the critical micelle concentration the lipid bilayer is 
disrupted and fragments.  Ultimately, at high detergent concentrations, detergent-lipid 
mixed micelles are generated (1).  Although some proteins are sufficiently stable in the 
micelle to be studied despite removal from the membrane, some are not.  For instance, 
the initial detergent partitioning into the native bilayer has been shown to destabilize 
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rhodopsin even at concentrations below the critical micelle concentration (8).  Protein-
lipid interactions in a detergent micelle differ vastly from the interactions involved in a 
two-dimensional bilayer.  Thus, detergents cannot completely substitute for the stability 
of a bilayer and are unsuitable as membrane mimetic systems for many studies. 
 
 1.5 Membrane model systems 
1.5.1 Liposomes  
Membrane proteins may be studied in liposomes, lipid vesicles that provide a 
reconstituted bilayer of well-defined lipids.  To form liposomes, hydrated lipid 
suspensions are mechanically agitated by sonication, successively freeze-dried in liquid 
nitrogen or extruded through a membrane filter of a particular size (9).  Liposomes can be 
unilamellar or multilamellar and typically form heterogeneously with physical 
dimensions on the order of a few hundred nanometers in diameter.  Only one side of 
membrane proteins is accessible for experiments when reconstituted in liposomes (6).  
Due to their large size, liposomes are unsuitable for spectrophotometric studies, because 
they scatter more light in the UV-Visible range than they transmit.  This light scattering 
produces an exceptionally high absorbance signal that is outside the linear range, so that 
absorbance measurements at 280 nm are no longer directly proportional to protein 
concentration.  Liposomes are also problematic for spectroscopy studies such as nuclear 
magnetic resonance spectroscopy (NMR) and circular dichroism (CD) on membrane 
proteins.  Large molecules tumble slower with longer rotational correlation times, which 
ultimately contribute to spectral line broadening and limit the size of protein that can be 
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studied using NMR.  Liposomes are also incompatible for CD because their large 
dimensions can scatter light of high enough intensity to interfere with the measurement. 
 
 1.5.2 Nanodiscs 
Nanodiscs provide a valuable system in which to study membrane proteins.  It is a 
membrane model system that consists of a planar, discoidal phospholipid bilayer with the 
hydrophobic core of the bilayer encircled by two belts of membrane scaffolding protein 
(MSP).  Derived from lipoproteins, the membrane scaffolding protein length determines 
the diameter of the nanodisc, which may range from 10 nm to 12 nm or higher depending 
on the protein construct (10, 11).  Nanodiscs are formed as follows.  Detergent is added 
to solubilize membrane proteins from the native membrane.  Detergent solubilized 
membrane proteins are mixed with MSP and phospholipids at an experimentally defined 
ratio (10-12).  As detergent is removed from the system, the MSPs coil around 
phospholipids that surround the membrane protein in an energetically spontaneous 
process to form nanodiscs (12).  One and two rhodopsins have been reconstituted into 
nanodiscs at specific protein to lipid ratios (13).  Nanodiscs offer the advantages of 
smaller size, a bilayer environment, and access to both sides of the embedded protein.  
However, protein stability may be irreversibly affected prior to detergent removal.  In 
addition, absorbance of the membrane scaffolding protein at 280 nm may interfere with 
UV-Vis spectroscopic studies (6). 
 
1.6 Lipodisq® nano-particles 
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Amphipathic polymers have been developed to form nanoscale lipid-polymer 
assemblies for drug delivery purposes and to serve as membrane mimetics for biophysical 
studies of membrane proteins.  As was the case for nanodiscs, preparation of membrane 
mimetics using many of these amphipathic polymers requires the addition of detergent (6, 
7, 14).  However, unlike other amphipathic polymers, 3:1 styrene-maleic acid copolymer 
has been used for the detergent-free preparation of Lipodisq® nano-particles (15-17).  
 
The 3:1 styrene-maleic acid copolymer can be used at physiologically relevant 
temperatures and pH values (6).  It is believed to hypercoil around phospholipids such as 
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) to form discoidal lipid bilayer (6).  
Both BR, with seven transmembrane α-helices, and PagP, a β-barrel, are model 
membrane proteins that have been incorporated as single-molecules into Lipodisq® nano-
particles (15).  Previous studies have characterized the average size of empty and BR-
containing Lipodisq® nanoparticles to be smaller in diameter than MSP-bound nanodiscs 
(15-17).  Transmission electron microscopy (TEM) studies have corroborated the results 
from dynamic light scattering (DLS) and support the model that Lipodisq® nano-particles 
are discoidal structures that range between 5-13 nm in diameter (15, 16). 
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Lipodisq® nano-particles are a developing platform that may be used to study 
membrane proteins using various kinds of spectroscopy and single-molecule techniques. 
Lipodisq® nano-particles have similar advantages as nanodiscs without the disadvantage 
of absorbance at 280 nm of the membrane scaffolding proteins.  Bacteriorhodopsin 
incorporated into Lipodisq® nano-particles have been studied with many spectroscopic 
techniques including NMR, ESR (DEER), CD and characterized by negative stain TEM 
and DLS (15-17).   
 
1.7 Dynamic light scattering 
Light scattering is a universal property of molecules that arises from the 
polarizability of the electron cloud at the atomic level. While static light scattering detects 
the time-averaged intensity of light by observing a large sample volume, dynamic light 
scattering detects the individual fluctuations in scattering intensity in a small sample 
volume (18).  Dynamic light scattering is a noninvasive and highly sensitive biophysical 
technique that is capable of detecting a wide range of particle sizes.  DLS can provide a 
qualitative analysis of the stability of a sample with respect to changes in the light 
scattering intensity profile (19, 20).  
The technique utilizes a laser beam that provides a monochromatic and coherent 
light source to directly measure molecules undergoing Brownian motion (19-21).  
Brownian motion corresponds to the random, stochastic collisions between molecules.  
The instrument detects the minute time-dependent fluctuations of light scattering 
intensity from the sample and generates an autocorrelation function that decays over time 
(21).  
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The intensity of light scattered at any second in time during the measurement can 
be quantified as the photon count rate in kilo counts per second (kcps) (22).  The count 
rate can provide information about the concentration of the sample.  An increase in the 
sample concentration corresponds to an increase in count rate, while a decrease in sample 
concentration corresponds to a decrease in count rate (22).  The time dependent trend of 
the count rate for the sample can indicate aggregation if the count rate increases over time 
or sedimentation if the count rate decreases over time (19).  
The shape of the autocorrelation decay function provides qualitative information 
about the sample.  Larger molecules scatter more light to the detector than smaller 
molecules and produce an autocorrelation function that decays over a longer time.  The 
width of the autocorrelation function between the time of maximum and minimum 
correlation is a graphical indicator of the polydispersity of the sample (22). The 
autocorrelation decay can be fit with either a single exponential (known as Cumulants 
analysis) or a multiple exponential algorithm (22). A translational diffusion coefficient 
that describes a hard sphere with a hydrodynamic Stokes radius is calculated directly 
from the fit of the autocorrelation decay (21).  
Cumulants analysis of the autocorrelation function calculates the average 
hydrodynamic diameter (Z-average diameter) and the polydispersity index (PdI) of the 
sample.  The polydispersity index is a dimensionless scale between zero and one that 
quantifies the degree of polydispersity of a sample (22).  Values closer to zero represent 
increasingly monodispersed sample composition, while values greater than 0.7 indicates 
that the sample may be too polydisperse for meaningful DLS analysis. The Z-average 
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diameter is a value that may be used to compare various unimodal intensity distributions 
with polydispersity values less than 0.3 (19, 22).    
Size distributions can be plotted by assuming that the sample consists of a 
continuous distribution of hydrodynamic radii.  A size distribution by intensity is 
generated directly from the autocorrelation fit by plotting the relative scattering intensity 
of species in the sample population against the size of each species (21).  The intensity 
distribution is most suited for meaningful analysis when there is a single peak in the 
profile (19).  Rayleigh scattering theory is appropriate for analysis of spherical particles 
that are much smaller in size than the wavelength of the incident light (21).  Under the 
Rayleigh approximation, 𝐼 ∝ 𝑑!, where I is the intensity of the scattered light and d is the 
diameter of the particle (21). Non-spherical particles, including discoidal particles, are 
analyzed as spherical particles and described by a hydrodynamic diameter equivalent to 
the size of a spherical particle with the same translational diffusion coefficient (21). 
Under the conditions that there are multiple peaks, a size distribution by volume 
provides a more accurate depiction of the sample constituents.  In this case, the Rayleigh 
light scattering approximation is no longer appropriate since part of the sample consists 
of particles sizes on the order of wavelength of the incident light (21). Application of Mie 
theory is necessary to generate analytical solutions using the refractive index of the 
sample and transforms the intensity distribution into the volume distribution (19-21). 
 
1.8 Study design 
This study investigate will the stability of Lipodisq® nano-particles consisting of 
only the SMA polymer and phospholipids (empty Lipodisq® nano-particles) and those 
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containing phospholipids and BR (BR Lipodisq® nano-particles) for up to two days.  The 
phospholipid, 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) with no unsaturated 
acyl chains (14:0 PC), will be used for all of the following experiments. Lipodisq® 
nanoparticles will be measured at 20 and 30°C bordering the lipid phase transition of 
DMPC (Tm = 23°C).  For the purposes of this study, dynamic light scattering will be used 
to follow the intensity distribution of Lipodisq® nano-particles, the smallest species, to 
determine if there is loss of intensity over 48 hours of measurement.  The migration of 
intensity from Lipodisq® nano-particles to larger species in the overall intensity 
distribution will be used as a qualitative measure of stability.  The stability of these 
Lipodisq® nano-particles over time will provide a relative time frame for which 
experiments can be conducted on incorporated proteins.  Bacteriorhodopsin will be used 
as a model protein for this study as it has been used in Lipodisq® nano-particles 
previously for comparison (15, 17). 
 
Chapter II. Methods  
2.1 Materials  
Lipids were purchased from Avanti Polar Lipids, Inc. and provided by Dr. Nathan 
Alder (Department of Molecular and Cell Biology, University of Connecticut, Storrs, 
CT).  Dr. Anthony Watts (Department of Biochemistry, University of Oxford, UK) 
kindly provided the 3:1 styrene-maleic acid (SMA) polymer obtained from Malvern 
Cosmeceutics Ltd.  Dr. Robert Birge from the (Department of Chemistry, University of 
Connecticut, Storrs, CT) kindly provided wild type purple membrane containing 
bacteriorhodopsin. 
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2.2 Formation of empty Lipodisq® nano-particles 
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) in chloroform was dried 
down under a nitrogen stream for approximately 20 minutes and put in a vacuum 
desiccator overnight to remove remaining traces of organic solvent.  The 3:1 styrene-
maleic acid (SMA) polymer was prepared to a 2.5% (w/v) solution in 50 mM Tris buffer 
(pH 8).  DMPC was hydrated to 20 mg/ml with the same buffer and sonicated in a water 
bath until opalescent.  DMPC liposomes were made by extruding 17X through 0.4 
micron membrane filters.  An equivolume amount of 2.5% SMA polymer solution was 
added to DMPC liposomes post extrusion and equilibrated on a shaker for one hour.  The 
solution (final volume: 500 µl) was centrifuged in a Beckman Coulter Optima™ 
ultracentrifuge (rotor: TLA100) at 20°C, 40,000 RCF, 5 acceleration/5 deacceleration for 
40 minutes.  The supernatant was then removed for dynamic light scattering 
measurements.  Low speed centrifugation at 6238 RCF was carried out in a RevSpin 102 
bench top centrifuge in an attempt to purify Lipodisq® nano-particles. 
 
2.3 Bacteriorhodopsin reconstitution into Lipodisq® nano-particles 
DMPC liposomes were prepared in 50mM Tris buffer (pH 8) with 300 mM NaCl. 
Wild type PM with BR was pelleted a Beckman Coulter Optima™ ultracentrifuge (rotor: 
TLA100) at 20°C, 40,000 RCF, 5 acceleration/5 deacceleration for 40 minutes.  Purple 
membrane was resuspended in DMPC liposomes that were extruded to 400 nm at a 1:5 
(wt:wt) ratio of PM:DMPC to reach a final protein to lipid ratio of approximately 1:172 
(17).  The sample was sonicated in a water bath without heating for approximately 30 
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minutes.  An equivolume amount of 2.5% SMA polymer solution was added to the 
suspension and equilibrated on a shaker for one hour.  The solution was centrifuged again 
under conditions for pelleting the PM for 40 minutes.   The supernatant was then 
removed for dynamic light scattering measurements.  
 
2.4 Dynamic light scattering experiments 
Dynamic light scattering experiments were carried out on a Zetasizer Nano S 
(Malvern) to determine the intensity distribution of Lipodisq® nano-particles.  Sets of ten 
experiments with ten seconds of data acquisition per experiment were carried out for each 
timed measurement at 15 minutes increments over the course of 48 hours.  For the 
purposes of generating size distributions, the refractive index of DMPC was set to 1.371 
(23, 24).  The refractive index of the dispersant was automatically set to 1.331. 
 
Chapter III. Results 
3.1 Optimization of Lipodisq® nano-particle formation 
DLS determinations were carried out to determine the size distribution of particles 
in the Lipodisq® preparation.  Figure 1 is representative of the data obtained from 
experiments conducted at 20°C.  These data indicate the smallest species exhibit mean 
diameters of approximately 6-8 nm and account for 95-100% of the total light scattering 
intensity.  The polydispersity indices ranged from 0.10-0.25 for these intensity 
distributions, which is consistent with values for a monodispersed sample.  
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Empty Lipodisq® nano-particles, the smallest species, have been purified using 
size exclusion column chromatography (15, 17).  We sought to simplify this procedure by 
using differential centrifugation. Lipodisq® nano-particles prepared by centrifugation of 
smaller total sample volumes and Lipodisq® nano-particles measured a week after 
preparation both exhibited polydisperse intensity distributions. Samples with 
polydisperse intensity distributions were subjected to centrifugation at 6238 RCF and 
40,000 RCF to determine whether empty Lipodisq® nano-particles may be purified using 
centrifugation (Figure 2a). Lipodisq® nano-particles of approximately 5 nm in diameter 
consisted 38.5% of the intensity distribution (Figure 2a) and 99.9% of the volume 
distribution (Figure 2b). After the 40 minutes of centrifugation at 40,000 RCF, Lipodisq® 
nano-particles of 7 nm in diameter consisted 73.3% of the intensity distribution. One 
hundred percent of the volume distribution consisted of 4 nm diameter Lipodisq® nano-
particles.  Accordingly, the decrease in photon count rate from 358 kcps to 219 kcps 
corresponded to the sample having a higher PdI (0.77) before than after (PdI= 0.38) 
centrifugation. Samples with polydisperse intensity distributions were centrifuged 6238 
RCF to determine if lower speeds would still produce significant recovery of intensity in 
Lipodisq® nano-particles (Figure 2c). Centrifugation at 40,000 RCF for 40 minutes 
showed approximately 26% increase in the intensity of Lipodisq® nano-particles, while 
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centrifugation at 6238 RCF produced only a slight difference in intensity. The latter 
change is probably within the bounds of experimental error.   
 
3.2 Stability of empty Lipodisq® nano-particles  
Polydisperse intensity distributions were observed after a week of preparation and 
led to further experiments to determine whether Lipodisq® nano-particles remain uniform 
in size or undergo significant aggregation into larger species. Since the size distribution 
by intensity weights large particles heavier than small particles, aggregates scatter enough 
light to disproportionately bias the intensity distribution.  For this reason, the size 
distribution by volume was monitored to provide a more accurate depiction of the sample 
(Figure 3a-b).  Although the intensity distribution of Lipodisq® nano-particles was 
observed in some of the experiments were polydisperse, DLS data indicates that 
Lipodisq® nano-particles contribute to greater than 99% of the sample volume (Figure 
3c). 
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We were interested in identifying a general time frame in which Lipodisq® nano-
particles remain stable.  This would be useful in experimental studies where these nano-
particles are used as a model membrane.  The size distribution changes in Lipodisq® 
nano-particles were followed at two temperatures, because we were interested in the 
stability at temperatures bordering the DMPC phase transition at 23°C. Over the course 
of 48 hours, intensity distributions of empty Lipodisq® nano-particles at 20°C varied 
negligibly from initial measurements (Figure 4).  Since Lipodisq® nano-particles had a 
more heterogeneous intensity distribution at 30°C (data not shown), the volume 
distribution was used to evaluate the stability (Figure 5).  Over the course of 48 hours, the 
volume distribution still consists only of Lipodisq® nano-particles. These data indicated 
that Lipodisq® nano-particles were stable for at least 48 hours after preparation.  
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In Figure 6, the change in percent intensity of Lipodisq® nano-particles was 
followed for up to 48 hours at both 20°C and 30°C. Although empty Lipodisq® nano-
particles had different initial intensities for experiments conducted at 20°C and consisted 
of more than 70% of the intensity distribution for at least 48 hours. (Figure 6a). Similarly, 
empty Lipodisq® nano-particles exhibited almost no change from initial contributions to 
the volume distributions in the experiments conducted at 30°C (Figure 6b).  Lipodisq® 
nano-particles consisted of almost 100% of the volume distribution for the entire 48 
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hours. These data reflect the uniformity of the size distributions for 48 hours both below 
and above the melting temperature of DMPC in Figures 4 and 5.  
 
 
3.3 Optimization of bacteriorhodopsin containing Lipodisq® nano-particles 
 Wild type bacteriorhodopsin in the purple membrane was not incorporated into 
Lipodisq® nano-particles (Figure 7).  Based on previous attempts to incorporate BR into 
Lipodisq® nano-particles for preliminary TEM studies (Figure 8), we expected to observe 
a hypsochromic shift in the absorbance spectra of BR due to incorporation of monomers 
instead of trimers (17). The expected shift in retinal absorbance peak from 568 nm to 555 
nm is absent in the absorbance spectrum of bacteriorhodopsin-incorporated Lipodisq® 
nano-particles.  
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Chapter IV. Discussion 
In previous studies, dynamic light scattering has been used to measure the 
diameter of empty Lipodisq® nano-particles to range between 5-12 nm in diameter (16).  
Similarly in this study, empty Lipodisq® nano-particles were the smallest species in the 
intensity distribution with Z-average diameters between 6 and 11 nm.  Low 
polydispersity index values of 0.10-0.25 and unimodal intensity and volume distributions 
were observed for all measurements.  These characteristics are consistent with the 
conclusion that empty Lipodisq® nano-particles are uniform in size and are the 
predominant species present in the volume distribution of the sample.  As a result, 
Lipodisq® nano-particles are readily identifiable using DLS measurements and DLS can 
be used to confirm the presence of empty Lipodisq® nano-particles in solution. 
Gel filtration chromatography has been used to separate BR Lipodisq® nano-
particles from empty ones (15, 17).  In general, column chromatography is a fairly high-
resolution method for purifying and isolating analytes of different sizes from solution. In 
this study, we investigated differential centrifugation as a direct, low-resolution method 
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for purifying Lipodisq® nano-particles that displayed polydisperse intensity distributions 
after formation. Centrifugation of the sample at 40,000 RCF for 40 minutes achieved 
approximately a 20% enrichment of intensity in the smallest species, the empty 
Lipodisq® nano-particles (Figure 2c). Thus, empty Lipodisq® nano-particles can be 
purified by centrifugation with forces of at least 40,000 RCF.  This has practical 
implications for the formation of Lipodisq® nano-particles. When Lipodisq® nano-
particles are formed and the sample is polydisperse, centrifugation can be used as a 
method of removing massive aggregates. The removal of aggregates effectively 
concentrates the Lipodisq® nano-particles into a more uniform population of sizes. 
Centrifugation may also be useful to remove aggregates after BR Lipodisq® nano-
particles are purified on a column.  This may be investigated further as a lower resolution 
method for purifying BR Lipodisq® nano-particles. 
After establishing that empty Lipodisq® nano-particles may be purified using 
differential centrifugation, we focused our efforts on identifying a valid time frame to 
conduct experiments on proteins incorporated into Lipodisq® nano-particles.  A 48-hour 
time course was carried out to determine the rate of change of the intensity distribution 
contributed by Lipodisq® nano-particles below and above the melting temperature of 
DMPC (23°C). At 20°C, intensity distributions were stable throughout each 12 hour 
period (Figure 4a-d) and the sample consists almost entirely of Lipodisq® nano-particles.  
At 30°C, intensity distributions were observed to vary between each 12 hour increment 
before settling into an equilibrium state of two peaks after the initial 12 hour period (data 
not shown). This may be due to the presence of larger species inducing a nucleation 
process that encourages formation of massive particles over time. However, aggregation 
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has minimal influence on the overall sample quality since Lipodisq® nano-particles still 
consist of the majority of the volume distribution (Figure 5a-d).  We concluded that 
empty Lipodisq® nano-particles are stable over the course of 48 hours at temperatures 
below and above the melting temperature.  This determined a time frame of at least 2 
days within which empty Lipodisq® nano-particles are stable experimental platforms.    
Bacteriorhodopsin was not incorporated for DLS studies using the experimental 
procedure described in the methods.  We believe that the lack of incorporation is due to 
the sonication step in which no heat was applied to the sample.  In previous literature, the 
purple membrane was sonicated with DMPC liposomes under gentle heating conditions 
(17).  
Further data must be collected on BR Lipodisq® nano-particles for comparison. 
Differential centrifugation will most likely be poorly equipped for separating empty 
Lipodisq® nano-particles from BR Lipodisq® nano-particles. Sucrose gradient 
centrifugation, which separates analytes based on their relative densities, may be a viable 
alternative for separating empty Lipodisq® nano-particles from BR Lipodisq® nano-
particles.  
Even without additional data, these experiments with empty nano-particles 
indicate that incorporation of bacteriorhodopsin from the purple membrane should not 
significantly impact stability since bacteriorhodopsin in the purple membrane alone is 
extremely stable.  DLS size distributions of bacteriorhodopsin-incorporated Lipodisq® 
nano-particles would most likely be consistent with results obtained for empty nano-
particles since the hydrodynamic radius would not be expected to alter significantly with 
protein incorporation.   
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Lipodisq® nano-particles may also be used to incorporate other membrane 
proteins in different lipid environments. Varying lipid and protein type in these Lipodisq® 
nano-particles may limit the time frame in which experiments can be conducted. This will 
depend on the stability of the type of lipid or protein. Individual proteins may have 
properties that limit their stability when incorporated into Lipodisq® nano-particles. In 
addition, replacing saturated DMPC with other unsaturated lipids may impose a limit on 
the stability of Lipodisq® nano-particles since unsaturated lipids spontaneously oxidize 
over time.   
 In conclusion, studies using Lipodisq® nano-particles can be conducted for at least 
48 hours with minimal formation of aggregate species. Samples can be stored at 
temperatures up to 30°C with little to no effect on uniformity for at least 48 hours. 
Beyond 48 hours, it is advisable to centrifuge at 40,000 RCF for 40 minutes to pellet 
massive aggregates and recover a more monodispersed sample of Lipodisq® nano-
particles.  
 
 
 
 
 
 
 
 
 
	   
27	  
References 
1. Luckey M. Membrane structural biology with biochemical and biophysical foundations. New York, NY, 
USA: Cambridge University Press; 2008. 
2. Stoeckenius W, Lozier RH, Bogomolni RA. Bacteriorhodopsin and the purple membrane of 
halobacteria. Biochim Biophys Acta. 1979 Mar 14;505(3-4):215-78. 
3. Rehorek M, Heyn MP. Binding of all-trans-retinal to the purple membrane. evidence for cooperativity 
and determination of the extinction coefficient. Biochemistry. 1979 Oct 30;18(22):4977-83. 
4. Haupts U, Tittor J, Oesterhelt D. Closing in on bacteriorhodopsin: Progress in understanding the 
molecule. Annu Rev Biophys Biomol Struct. 1999;28:367-99. 
5. Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH. An atomic model for the 
structure of bacteriorhodopsin. Biochem Soc Trans. 1990 Oct;18(5):844. 
6. Rajesh S, Knowles T, Overduin M. Production of membrane proteins without cells or detergents. N 
Biotechnol. 2011 Apr 30;28(3):250-4. 
7. Jamshad M, Lin YP, Knowles TJ, Parslow RA, Harris C, Wheatley M, et al. Surfactant-free purification 
of membrane proteins with intact native membrane environment. Biochem Soc Trans. 2011 Jun;39(3):813-
8. 
8. Corley SC, Sprangers P, Albert AD. The bilayer enhances rhodopsin kinetic stability in bovine rod outer 
segment disk membranes. Biophys J. 2011 Jun 22;100(12):2946-54. 
9. Banerjee RK, Datta AG. Proteoliposome as the model for the study of membrane-bound enzymes and 
transport proteins. Mol Cell Biochem. 1983;50(1):3-15. 
10. Bayburt TH, Carlson JW, Sligar SG. Reconstitution and imaging of a membrane protein in a 
nanometer-size phospholipid bilayer. J Struct Biol. 1998 Sep;123(1):37-44. 
11. Bayburt TH, Sligar SG. Membrane protein assembly into nanodiscs. FEBS Lett. 2010 May 
3;584(9):1721-7. 
12. Bayburt TH, Sligar SG. Self-assembly of single integral membrane proteins into soluble nanoscale 
phospholipid bilayers. Protein Sci. 2003 Nov;12(11):2476-81. 
13. Bayburt TH, Leitz AJ, Xie G, Oprian DD, Sligar SG. Transducin activation by nanoscale lipid bilayers 
containing one and two rhodopsins. J Biol Chem. 2007 May 18;282(20):14875-81. 
14. Tonge SR, Tighe BJ. Responsive hydrophobically associating polymers: A review of structure and 
properties. Adv Drug Deliv Rev. 2001 Dec 3;53(1):109-22. 
15. Knowles TJ, Finka R, Smith C, Lin YP, Dafforn T, Overduin M. Membrane proteins solubilized intact 
in lipid containing nanoparticles bounded by styrene maleic acid copolymer. J Am Chem Soc. 2009 Jun 
10;131(22):7484-5. 
16. Orwick MC, Judge PJ, Procek J, Lindholm L, Graziadei A, Engel A, et al. Detergent-free formation and 
physicochemical characterization of nanosized lipid?polymer complexes: Lipodisq. Angewandte Chemie 
International Edition. 2012:n/a,n/a. 
  
28 
17. Orwick-Rydmark M, Lovett JE, Graziadei A, Lindholm L, Hicks MR, Watts A. Detergent-free 
incorporation of a seven-transmembrane receptor protein into nanosized bilayer lipodisq particles for 
functional and biophysical studies. Nano Lett. 2012 Sep 12;12(9):4687-92. 
18. Van Holde KKE, Johnson WC, Ho PS. Principles of physical biochemistry. Pearson Education, 
Limited; 2006. 
19.  Nanocomposix's guide to dynamic light scattering measurement and analysis. San Diego, CA, USA: 
2012. Report No.: v1.3. 
20. Chapter 14: Size theory. In: Zetasizer Nano Series Manual. Malvern Instruments Ltdp. 14.1. 
21. DLS technical note. Dynamic light scattering: An introduction in 30 minutes. Worcestershire, UK: 
Malvern Instruments Ltd; . 
22. Dynamic light scattering common terms defined. Worcestershire, UK: Malvern Instruments Ltd; 2011. 
23. Cherry RJ, Chapman D. Refractive index determination of lecithin black films. J Mol Biol. 1967 Dec 
28;30(3):551-3. 
24. Sikor M, Sabin J, Keyvanloo A, Schneider MF, Thewalt JL, Bailey AE, et al. Interaction of a charged 
polymer with zwitterionic lipid vesicles. Langmuir. 2010 Mar 16;26(6):4095-102. 
 
 
  
 
 
 
 
